English High Court invalidates Symbicort patent

03-09-2014

English High Court invalidates Symbicort patent

sarra22 / Shutterstock.com

English High Court Justice Philip James Sales has found a patent covering AstraZeneca’s bestselling drug Symbicort invalid after a challenge by Israeli generic drug maker Teva.


English High Court, AstraZeneca, Symbicort, Teva, DuoResp Spiromax

LSIPR